Literature DB >> 24347729

Frequent exposure to suboptimal temperatures in vaccine cold-chain system in India: results of temperature monitoring in 10 states.

Manoj V Murhekar1, Srihari Dutta2, Ambujam Nair Kapoor3, Sailaja Bitragunta4, Raja Dodum5, Pramit Ghosh6, Karumanagounder Kolanda Swamy7, Kalyanranjan Mukhopadhyay8, Somorjit Ningombam9, Kamlesh Parmar10, Devegowda Ravishankar11, Balraj Singh12, Varsha Singh13, Rajesh Sisodiya14, Ramaratnam Subramanian7, Tana Takum5.   

Abstract

OBJECTIVE: To estimate the proportion of time the vaccines in the cold-chain system in India are exposed to temperatures of < 0 or > 8 °C.
METHODS: In each of 10 states, the largest district and the one most distant from the state capital were selected for study. Four boxes, each containing an electronic temperature recorder and two vials of diphtheria, pertussis and tetanus vaccine, were placed in the state or regional vaccine store for each study state. Two of these boxes were then shipped - one per facility - towards the two most peripheral health facilities where vaccine was stored in each study district. The boxes were shipped, handled and stored as if they were routine vaccine supplies.
FINDINGS: In state, regional and district vaccine stores and peripheral health facilities, respectively, the temperatures in the boxes exceeded 8 °C for 14.3%, 13.2%, 8.3% and 14.7% of their combined storage times and fell below 0 °C for 1.5%, 0.2%, 0.6% and 10.5% of these times. The boxes also spent about 18% and 7% of their combined times in transit at < 0 and > 8 °C, respectively. In shake tests conducted at the end of the study, two thirds of the vaccine vials in the boxes showed evidence of freezing.
CONCLUSION: While exposure to temperatures above 8 °C occurred at every level of vaccine storage, exposure to subzero temperatures was only frequent during vaccine storage at peripheral facilities and vaccine transportation. Systematic efforts are needed to improve temperature monitoring in the cold-chain system in India.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24347729      PMCID: PMC3845272          DOI: 10.2471/BLT.13.119974

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  16 in total

1.  Evaluation of the cold-chain for oral polio vaccine in a rural district of India.

Authors:  Yogindra Samant; Hemant Lanjewar; David Parker; Lester Block; Gajendra S Tomar; Ben Stein
Journal:  Public Health Rep       Date:  2007 Jan-Feb       Impact factor: 2.792

2.  Monitoring temperatures in the vaccine cold chain in Bolivia.

Authors:  Carib Nelson; Paulo Froes; Anne Mie Van Dyck; Jeaneth Chavarría; Enrique Boda; Alberto Coca; Gladys Crespo; Heinz Lima
Journal:  Vaccine       Date:  2006-08-28       Impact factor: 3.641

Review 3.  Freezing temperatures in the vaccine cold chain: a systematic literature review.

Authors:  Dipika M Matthias; Joanie Robertson; Michelle M Garrison; Sophie Newland; Carib Nelson
Journal:  Vaccine       Date:  2007-03-07       Impact factor: 3.641

4.  Status of cold-chain maintenance in Chandigarh.

Authors:  N K Goel; R Pathak; A Galhotra; C Dankal; H M Swami
Journal:  Indian J Public Health       Date:  2008 Jan-Mar

5.  Field trial on frozen and thawed tetanus toxoid.

Authors:  P S Menon; G Sahai; V B Joshi; R G Murthy; M S Boparai; A K Thomas
Journal:  Indian J Med Res       Date:  1976-01       Impact factor: 2.375

6.  Surveillance of cold chain system during intensified pulse polio programme--2006 in Chandigarh.

Authors:  Abhiruchi Galhotra; Naveen K Goel; Rambha Pathak; Rajinder Kumar; H M Swami
Journal:  Indian J Pediatr       Date:  2007-08       Impact factor: 1.967

7.  Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles.

Authors:  D Diminsky; N Moav; M Gorecki; Y Barenholz
Journal:  Vaccine       Date:  1999-08-20       Impact factor: 3.641

8.  Comparison of hepatitis B vaccine coverage and effectiveness among urban and rural Mongolian 2-year-olds.

Authors:  James S Edstam; Nyamkhuu Dulmaa; Pagbajabyn Nymadawa; Arslan Rinchin; J Khulan; Ann Marie Kimball
Journal:  Prev Med       Date:  2002-02       Impact factor: 4.018

9.  Storage at -3 degrees C for 24 h alters the immunogenicity of pertussis vaccines.

Authors:  C A Boros; M Hanlon; M S Gold; D M Roberton
Journal:  Vaccine       Date:  2001-05-14       Impact factor: 3.641

10.  Exposure of hepatitis B vaccine to freezing temperatures during transport to rural health centers in Mongolia.

Authors:  James S Edstam; Nyamkhuu Dulmaa; Orgil Tsendjav; Baasandorj Dambasuren; Batochir Densmaa
Journal:  Prev Med       Date:  2004-08       Impact factor: 4.018

View more
  22 in total

1.  Design and Optimization of a Temperature-Stable Dry Powder BCG Vaccine.

Authors:  Dominique N Price; Nitesh K Kunda; Rajaun Ellis; Pavan Muttil
Journal:  Pharm Res       Date:  2019-12-23       Impact factor: 4.580

2.  Evaluation of the Universal Immunization Program and Challenges in Coverage of Migrant Children in Haridwar, Uttarakhand, India.

Authors:  Latika Nath; Prabhdeep Kaur; Saurabh Tripathi
Journal:  Indian J Community Med       Date:  2015 Oct-Dec

3.  Factors associated with the exposure of vaccines to adverse temperature conditions: the case of North West region, Cameroon.

Authors:  Martin Ndinakie Yakum; Jérôme Ateudjieu; Fida Ramsina Pélagie; Ebile Akoh Walter; Pierre Watcho
Journal:  BMC Res Notes       Date:  2015-06-30

4.  Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.

Authors:  Radboud J Duintjer Tebbens; Lee M Hampton; Kimberly M Thompson
Journal:  BMC Infect Dis       Date:  2016-06-01       Impact factor: 3.090

5.  Root cause analysis underscores the importance of understanding, addressing, and communicating cold chain equipment failures to improve equipment performance.

Authors:  Pat Lennon; Brian Atuhaire; Shahrzad Yavari; Vidya Sampath; Mercy Mvundura; Nithya Ramanathan; Joanie Robertson
Journal:  Vaccine       Date:  2017-04-19       Impact factor: 3.641

6.  Optical Detection of Degraded Therapeutic Proteins.

Authors:  William F Herrington; Gajendra P Singh; Di Wu; Paul W Barone; William Hancock; Rajeev J Ram
Journal:  Sci Rep       Date:  2018-03-23       Impact factor: 4.379

7.  Cold-Chain Adaptability During Introduction of Inactivated Polio Vaccine in Bangladesh, 2015.

Authors:  Mallick M Billah; K Zaman; Concepcion F Estivariz; Cynthia J Snider; Abhijeet Anand; Lee M Hampton; Tajul I A Bari; Kevin L Russell; Shua J Chai
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

8.  Assessment of temperatures in the vaccine cold chain in two provinces in Lao People's Democratic Republic: a cross-sectional pilot study.

Authors:  Tomomi Kitamura; Viraneth Bouakhasith; Kongxay Phounphenghack; Chansay Pathammavong; Anonh Xeuatvongsa; Masataro Norizuki; Hironori Okabayashi; Yoshio Mori; Munehito Machida; Masahiko Hachiya
Journal:  BMC Res Notes       Date:  2018-04-27

Review 9.  Tools and approaches to ensure quality of vaccines throughout the cold chain.

Authors:  Umit Kartoglu; Julie Milstien
Journal:  Expert Rev Vaccines       Date:  2014-05-28       Impact factor: 5.217

10.  Can thermostable vaccines help address cold-chain challenges? Results from stakeholder interviews in six low- and middle-income countries.

Authors:  Debra D Kristensen; Tina Lorenson; Kate Bartholomew; Shirley Villadiego
Journal:  Vaccine       Date:  2016-01-08       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.